Electronic cigarette maker Logic Technology recently announced that Keith Ablow,
M.D., will be conducting an expanded clinical study of Logic EGO
CE4 in his practice to determine their effects on reducing or
eliminating tobacco product usage. Previously, Dr. Ablow reported that three
individuals had ceased smoking when given e-cigarettes as part of a smoking
cessation regimen.
Sponsored by Logic, Dr. Ablow's study will monitor and
track patients' experiences using e-cigarettes to determine the product
category's effectiveness for transitioning smokers from traditional cigarettes
to a tobacco-free, smokeless, battery-operated nicotine delivery
device.
The study, to be conducted over a 12-week period, will offer
patients who use traditional cigarettes the option to try ego
t electronic cigarette. Dr. Ablow will provide participating
patients with e-cigarettes and measure their use of this technology and tobacco
products over the course of the 12 weeks.
Simulating the feeling and
taste of a real cigarette, Logic provides a sensory experience that satisfies a
smoker's addictive cravings for the nicotine, tobacco flavor, hand-to-mouth
motion and vapor release, while avoiding 4,000 toxins that are in cigarettes,
according to the company. Unlike other nicotine delivery devices, an e-cigarette
can assuage the desire for a traditional cigarette and deliver a realistic
smoking experience, the company added.fsfd3WD3x
"We are thrilled to work
with distinguished psychiatrist Dr. Keith Ablow to conduct this study," said Eli
Alelov, CEO of Logic Technology, Livingston, N.J. "Minimal statistical data
exists about ego-t
battery and their effectiveness in supporting a switch from
traditional cigarettes, and we think it is imperative to educate the public on
the benefits of this product. We think Dr. Ablow's findings will support the
rapidly growing industry and prove what we have been saying for years, that
Logic is a smarter alternative helping to convert American smokers to better
choices."
"I reached out to Logic about this informal, expanded series of
clinical case studies because I cannot understand why universities and the
government are not aggressively exploring the use of electronic cigarettes to
help smokers stop using tobacco," said Ablow. "I am a supporter of rechargeable
electronic cigarette in aiding patients to make smarter choices
with their smoking habits."
Logic will provide a findings update as the
study moves forward.
No comments:
Post a Comment